SEARCH RESULTS

43 RESULTS

Todd E. Golde on Naproxen/Rofecoxib Trial Results Published

COMMENT The study by Aisen et al. shows no benefit to rofecoxib or naproxen in patients with mild to moderate AD. Nevertheless, this negative study is an important contribution to the collective effort to evaluate therapeutic strategies to treat or prevent AD. Th

Current Filters

  • TYPE: Comment x
  • Commentator: Golde, Todd E x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE